Company / Capital Returned to Shareholders
Coherus Oncology, Inc. Capital Returned to Shareholders History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders
$2.0K
FY2016
5-year range
$2.0K / $2.0K
FY2014-FY2016
Trend
+0.0%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Returned to Shareholders remained relatively stable over the past 3 years, with values between $2,000 and $2,000.
Based on SEC 10-K filings.
$2,000 in FY2016.
Remained stable around $2,000 over the past 2 years.
Capital Returned to Shareholders over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, capital returned to shareholders increased 0.0% year-over-year.
Company context
Key Data Points
- Altman Z-Score -0.49 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to ShareholdersValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $2.0K | +0.0% |
| FY2015 | $2.0K | +0.0% |
| FY2014 | $2.0K | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026